Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 12

Results: 13

HO production within tumor microenvironment inversely correlated with infiltration of CD56 NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1801, doi. 10.1007/s00262-011-1082-7

By:

Izawa, Shinichirou;
Kono, Koji;
Mimura, Kousaku;
Kawaguchi, Yoshihiko;
Watanabe, Mitsuaki;
Maruyama, Takanori;
Fujii, Hideki

Publication type:

Article

Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1683, doi. 10.1007/s00262-011-1067-6

By:

Moustaki, Ardiana;
Argyropoulos, Kimon;
Baxevanis, Constantin;
Papamichail, Michael;
Perez, Sonia

Publication type:

Article

Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1697, doi. 10.1007/s00262-011-1066-7

By:

Jeon, Yoon;
Min, Hye;
Lee, Yoo;
Kang, Byung;
Kim, Eun;
Park, Hyo;
Bae, Youngmee;
Lee, Hyun;
Park, Weon;
Song, Hyung;
Jung, Kyeong;
Park, Seong

Publication type:

Article

In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1707, doi. 10.1007/s00262-011-1056-9

By:

Thakur, Archana;
Norkina, Oxana;
Lum, Lawrence

Publication type:

Article

Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1721, doi. 10.1007/s00262-011-1073-8

By:

Suzuki, Kei;
Kadota, Kyuichi;
Sima, Camelia;
Sadelain, Michel;
Rusch, Valerie;
Travis, William;
Adusumilli, Prasad

Publication type:

Article

Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1789, doi. 10.1007/s00262-011-1072-9

By:

Gubbels, Jennifer;
Gadbaw, Brian;
Buhtoiarov, Ilia;
Horibata, Sachi;
Kapur, Arvinder;
Patel, Dhara;
Hank, Jacquelyn;
Gillies, Stephen;
Sondel, Paul;
Patankar, Manish;
Connor, Joseph

Publication type:

Article

A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1739, doi. 10.1007/s00262-011-1069-4

By:

Cantini, Gabriele;
Pisati, Federica;
Mastropietro, Alfonso;
Frattini, Véronique;
Iwakura, Yoichiro;
Finocchiaro, Gaetano;
Pellegatta, Serena

Publication type:

Article

Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1751, doi. 10.1007/s00262-011-1070-y

By:

Goodyear, Oliver;
Pearce, Hayden;
Pratt, Guy;
Moss, Paul

Publication type:

Article

Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1763, doi. 10.1007/s00262-011-1076-5

By:

Yan, Xiaoli;
Zhang, Xiaojun;
Wang, Yanzhong;
Li, Xinghui;
Wang, Saifeng;
Zhao, Bao;
Li, Yang;
Ju, Ying;
Chen, Lizhao;
Liu, Wenjun;
Meng, Songdong

Publication type:

Article

Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1775, doi. 10.1007/s00262-011-1075-6

By:

Smith, Shannon;
Hoelzinger, Dominique;
Dominguez, Ana;
Snick, Jacques;
Lustgarten, Joseph

Publication type:

Article

Prognostic impact of B-cell density in cutaneous melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1729, doi. 10.1007/s00262-011-1071-x

By:

Ladányi, Andrea;
Kiss, Judit;
Mohos, Anita;
Somlai, Beáta;
Liszkay, Gabriella;
Gilde, Katalin;
Fejős, Zsuzsanna;
Gaudi, István;
Dobos, Judit;
Tímár, József

Publication type:

Article

Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1669, doi. 10.1007/s00262-011-1118-z

By:

Ersvær, Elisabeth;
Melve, Guro;
Bruserud, Øystein

Publication type:

Article

Antigens in chronic myeloid leukemia: implications for vaccine development.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1655, doi. 10.1007/s00262-011-1126-z

By:

Šmahel, Michal

Publication type:

Article